Skip to main content
OpenTrials

Clinical trial condition

Malignant Melanoma

Explore clinical trials studying Malignant Melanoma. Study availability and eligibility vary by location and protocol.

168 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Malignant Melanoma trial results

Completed

Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)

NCT03820986

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations
  • The Angeles Clinic and Research Institute ( Site 0707) Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0704) San Francisco, California, United States
  • California Pacific Medical Center Research Institute ( Site 0705) San Francisco, California, United States
  • John Wayne Cancer Institute ( Site 0706) Santa Monica, California, United States
View all 119 locations
View Trial Details
Completed

Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study

NCT04889118

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations
  • Beijing Cancer Hospital (0601) Beijing, Beijing Municipality, China
  • Fujian Provincial Cancer Hospital ( Site 0612) Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer Center (0602) Guangzhou, Guangdong, China
  • Henan Cancer Hospital ( Site 0610) Zhengzhou, Henan, China
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details

Related conditions